New Delhi: Torrent Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed ...

PLAINSBORO, N.J., March 29, 2025 /PRNewswire/ -- Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial investigating the effects of Rybelsus ® (semaglutide) tablets ...

Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the ...

In 2019, an oral form of semaglutide was approved in 7- and 14-mg tablets for type 2 diabetes, sold under the trade name Rybelsus. In 2021, semaglutide was approved in a 2.4-mg dose for chronic ...

Novo Nordisk markets its semaglutide medicines as Ozempic pre-filled pens and Rybelsus oral tablets for type II diabetes ... for around $41 billion, or 14%, of the total gross covered prescription ...

Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the ...

(14). These ingredients must ... and not the name of the salt (e.g., ‘newdrug tablets’—not ‘newdrug hydrochloride tablets’). 2. The strength also will be expressed in terms of the active moiety (e.g., ...

Patients who take the common blood pressure medicine Lercanidipine HCI 20 mg tablets (lercanidipine hydrochloride ... Malaga, Spain, 11-14 May) shows that women are much more aware of ...

3 Semaglutide has been approved by the FDA in both long-acting injectable (Wegovy and Ozempic) and daily oral tablet (Rybelsus ... with a maximal dose of 14 mg or placebo (n = 4825), as well as ...

atherosclerotic cardiovascular disease and/or chronic kidney disease to either once-daily oral semaglutide at a maximum dose of 14 mg or placebo in addition to standard care. In both arms, about 27% ...

Rybelsus ® reduced major adverse cardiovascular events by 14% vs placebo in adults with ... stroke and CV death in those treated with oral semaglutide vs placebo. The proven cardiovascular ...